Erie Indemnity Company (ERIE) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 14/100
- 10Y CAGR
- 10.4%
- Median YoY
- 6.2%
- YoY volatility
- σ 21.4pp· choppy
- Quarters ≥ 20%
- 4 of 40
- Negative quarters
- 2
- Valuation vs own 10Y history
- P/S 3.4x · 10Y median 4.3x · 9th percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 4 of 40 → 4 of 40 pts
- Steadiness (typical swing 21.4pp) → 9.7 of 25 pts
- Pace (median 6.2% YoY) → 0 of 20 pts
- Latest quarter (2.8% YoY) → 0 of 15 pts
- Score: 14 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 10.4% | 6.2% | 21.4pp | 4 of 40 | 2 |
| EPSEPS | 12.3% | 10.9% | 28.2pp | 14 of 40 | 11 |
| Op cash flowOperating cash flow | 12.2% | 13.1% | 65.6pp | 16 of 38 | 15 |
| EBITDAEBITDA | 12.3% | 10% | 24.3pp | 11 of 40 | 13 |
| FCFFree cash flow | 10.8% | 13.3% | 120.9pp | 14 of 36 | 12 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: ERIE on the compounders surface · All compounders, ranked